| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 103,752 | 93,900 | 103,375 | 126,581 | | Cost of Revenue | 58,871 | 54,087 | 68,303 | 78,318 | | | Gross Profit | 44,881 | 39,813 | 35,072 | 48,263 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,595 | 44,965 | 47,673 | 58,055 | | Non Recurring |
-
|
-
|
-
| 3,028 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 286 | (5,152) | (12,601) | (12,820) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (193) | 73 | (193) | (6,110) | | Earnings Before Interest And Taxes | 93 | (5,079) | (12,794) | (18,930) | | Interest Expense |
-
|
-
|
-
| (2,477) | | Income Before Tax | 93 | (5,079) | (12,794) | (16,453) | | Income Tax Expense | (93) | (1,813) | (4,626) | (4,452) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 186 | (3,266) | (8,168) | (12,001) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 186 | (3,266) | (8,168) | (12,001) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $186 | ($3,266) | ($8,168) | ($12,001) |
|
0.15% Nasdaq 
0.08 (0.85%) 
Income Statement
